📰 5 sources covering this story

Astra takes £18bn hit as merger talks get a thumbs down: Analysts 'perplexed' by £300bn tie-up with US rival

First covered 14 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Astra takes £18bn hit as merger talks get a thumbs down: Analysts 'perplexed' by £300bn tie-up with US rival
This is Money
This is Money1 hrs ago
Astra takes £18bn hit as merger talks get a thumbs down: Analysts 'perplexed' by £300bn tie-up with US rival
The FTSE 100 firm's long-serving boss Pascal Soriot (pictured) is said to be intent on pushing ahead with the merger which could be announced as soon as today.
AstraZeneca share prices drop amid £300bn mega-merger talks with US rival
The merger would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company
Evening Standard
Evening Standard🏁 first to report14 hrs ago
AstraZeneca in talks over £300bn mega-merger with US rival – reports
The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.
Irish News
Irish News14 hrs ago
AstraZeneca in talks over £300bn mega-merger with US rival – reports
The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →